Kuros Biosciences AG (SWX:KURN)
Switzerland
· Delayed Price · Currency is CHF 21.00
-0.92 (-4.20%)
Apr 29, 2026, 5:30 PM CET
Kuros Biosciences AG Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 19.77 | 19.76 | 16.87 | 26.03 | 31.4 | Upgrade
|
| Cash & Short-Term Investments | 19.77 | 19.76 | 16.87 | 26.03 | 31.4 | Upgrade
|
| Cash Growth | 0.03% | 17.12% | -35.17% | -17.11% | -2.14% | Upgrade
|
| Accounts Receivable | 30.21 | 14.69 | 7.61 | 3.05 | 1.85 | Upgrade
|
| Other Receivables | 9.98 | 3.01 | 1.43 | 0.87 | 0.39 | Upgrade
|
| Receivables | 40.2 | 17.7 | 9.05 | 3.91 | 2.25 | Upgrade
|
| Inventory | 21.35 | 10.36 | 5.77 | 3.43 | 1.93 | Upgrade
|
| Prepaid Expenses | 1.35 | 1.26 | 0.61 | 0.58 | 0.51 | Upgrade
|
| Total Current Assets | 82.67 | 49.08 | 32.29 | 33.95 | 36.08 | Upgrade
|
| Property, Plant & Equipment | 4.68 | 3.32 | 3.14 | 2.51 | 2.68 | Upgrade
|
| Goodwill | 24.3 | 21.31 | 29.06 | 31.7 | 36.63 | Upgrade
|
| Other Intangible Assets | 16.59 | 16.44 | 19.6 | 20.99 | 24.8 | Upgrade
|
| Long-Term Deferred Tax Assets | 5.32 | 2.56 | 0.76 | 0.55 | - | Upgrade
|
| Other Long-Term Assets | 0.32 | - | 0.02 | - | - | Upgrade
|
| Total Assets | 133.88 | 92.7 | 84.87 | 89.7 | 100.19 | Upgrade
|
| Accounts Payable | 13.81 | 7.58 | 1.55 | 1.41 | 0.93 | Upgrade
|
| Accrued Expenses | 27.18 | 14.76 | 9.42 | 5.44 | 3.94 | Upgrade
|
| Current Portion of Leases | 0.65 | 0.58 | 0.69 | 0.45 | 0.42 | Upgrade
|
| Other Current Liabilities | 0.5 | - | - | 6.32 | 7.09 | Upgrade
|
| Total Current Liabilities | 42.14 | 22.92 | 11.65 | 13.61 | 12.38 | Upgrade
|
| Long-Term Leases | 0.74 | 1.39 | 1.86 | 1.62 | 2.01 | Upgrade
|
| Pension & Post-Retirement Benefits | - | 0.15 | - | - | 0.39 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 2.94 | 0.36 | - | - | 0.98 | Upgrade
|
| Other Long-Term Liabilities | 3.58 | 3.46 | 4.01 | - | - | Upgrade
|
| Total Liabilities | 49.39 | 28.28 | 17.52 | 15.23 | 15.75 | Upgrade
|
| Common Stock | 3.23 | 3.07 | 4.37 | 3.95 | 3.6 | Upgrade
|
| Additional Paid-In Capital | 66.87 | 64.84 | 87.07 | 173.2 | 169.58 | Upgrade
|
| Retained Earnings | -37.79 | -40.76 | -50.06 | -125.27 | -111.44 | Upgrade
|
| Treasury Stock | - | - | -0.02 | -0.02 | -0.02 | Upgrade
|
| Comprehensive Income & Other | 52.17 | 37.27 | 25.99 | 22.6 | 22.72 | Upgrade
|
| Shareholders' Equity | 84.48 | 64.42 | 67.35 | 74.47 | 84.44 | Upgrade
|
| Total Liabilities & Equity | 133.88 | 92.7 | 84.87 | 89.7 | 100.19 | Upgrade
|
| Total Debt | 1.39 | 1.97 | 2.54 | 2.07 | 2.43 | Upgrade
|
| Net Cash (Debt) | 18.38 | 17.8 | 14.33 | 23.96 | 28.97 | Upgrade
|
| Net Cash Growth | 3.28% | 24.20% | -40.19% | -17.31% | -1.34% | Upgrade
|
| Net Cash Per Share | 0.44 | 0.48 | 0.39 | 0.71 | 0.88 | Upgrade
|
| Filing Date Shares Outstanding | 39.15 | 37.87 | 36.77 | 36.54 | 32.79 | Upgrade
|
| Total Common Shares Outstanding | 39.15 | 37.87 | 36.77 | 36.54 | 32.79 | Upgrade
|
| Working Capital | 40.52 | 26.16 | 20.64 | 20.34 | 23.7 | Upgrade
|
| Book Value Per Share | 2.16 | 1.70 | 1.83 | 2.04 | 2.57 | Upgrade
|
| Tangible Book Value | 43.59 | 26.67 | 18.69 | 21.77 | 23.01 | Upgrade
|
| Tangible Book Value Per Share | 1.11 | 0.70 | 0.51 | 0.60 | 0.70 | Upgrade
|
| Machinery | 5.18 | 2.94 | 2.08 | 1.64 | 1.3 | Upgrade
|
| Construction In Progress | 0.62 | - | - | - | - | Upgrade
|
| Leasehold Improvements | 0.1 | 0.07 | 0.05 | 0.05 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.